• Platinum Level Sponsor:
  • Gold Level Sponsor:
  • Silver Level Sponsor:
  • Silver Level Sponsor:
  • Bronze Level Sponsor:
  • Bronze Level Sponsor:
  • Travel Grants are sponsored by:
Home / Abstracts / Travel Grant Awardees

Travel Grant Awardees

Travel Grant Awardees 2013

The following authors and their poster presentations have been selected as Travel Grant Awardees in order to take part at this years MipTec.

P90 Identification of compounds improving the surface expression of mutant trafficking-deficient CNGA3-channels using an aequorin-based bioassay
J. Taeger* (1), P. Reuter (1), C. Schaerfe (2), K. Koeppen (3), O. Kohlbacher (2), B. Wissinger (1)

(1)University Clinics Tübingen (Tübingen, DE); (2)University of Tübingen (Tübingen, DE); (3)Dartmouth Medical School (Hanover, US)

P94 Protein-protein docking for the discovery of novel therapeutics that target the interaction between PTP1B and EGFR
J.A Ong*, T. Grewal, N.K Salam, D. Hibbs

The University of Sydney (Sydney, AU)

P97 Multiple drug design strategies for the discovery of new treatments for human African trypanosomiasis
E. Adjogatse* (1), P. Erskine (1), J. Kelly (2), S. Wood (1), J. Wilden (1), J. Cooper (1)

(1)University College London (London, GB); (2)London School of Hygiene and Tropical Medicine (London, GB)

P99 Discovery of Novel Natural Product Based Oxidosqualene Cyclase Inhibitors Using Combined Ligand and Structure Based Virtual Screening Methods
H. Moorthy*, N. Cerquiera, M. Ramos, P. Fernandes

University of Porto (Porto, PT)

P115 Integrative analysis of acute myeloid leukemia with genetic, epigenetic, and transcriptional data
S. Li* (1), F. Garrett-Bakelman (1), J. Patel (2), T. Hricik (2), R. Levine (2), A. Melnick (1), C. Mason (1)

(1)Weill Cornell Medical College (New York, US); (2)Memorial Sloan-Kettering Cancer Center (New York, US) 

P116 MeRIPPeR: MeRIP-Seq Peak-Finding and Analysis Suite
Y. Saletore*, C. Mason

Weill Cornell Medical College (New York, US)

P144 FRET-based calcium imaging: A tool for high throughput/content phenotypic drug screening in Alzheimer's disease
K. Honarnejad* (1), A. Daschner (1), A. Gehring (1), A. Szybinska (2), A. Kirsch (3), J. Kuznicki (2), F. Bracher (1), J. Herms (4)

(1)University of Munich (LMU) (Munich, DE); (2)International Institute of Molecular and Cell Biology (Warsaw, PL); (3)PerkinElmer Cellular Technologies Germany GmbH (Hamburg, DE); (4)German Center for Neurodegenerative Diseases (DZNE) (Munich, DE)

P185 Study of 1-hydroxy-2-methylanthraquinone and its derivatives on structure of the P53 core domain mutant Y220C: Study towards rational design of p53-stabilizing drugs
V. Ahire (1), C. Sasikumar (2), D. R. Majeti (3), S. Rajasekar (4), S. Priya Rajan* (5), V. Selvaprithiviraj (5), D. Viswanathan (4), A. Naqvi (6)

(1)University of Pune (Pune, IN); (2) Sathyabama University (Chennai, IN); (3)University Of Salford (Manchester, GB); (4) St. Joseph's College of Engineering (Chennai, IN); (5) Rajalakshmi Engineering College (Chennai, IN); (6)BioDiscovery Group- Solutions for future (Chennai, IN)

Travel Grant Awardees are young researchers and students that received excellent gradings of their abstract through the MipTec abstract peer review process.